Celltex Therapeutics Corporation Revenue and Competitors
Estimated Revenue & Valuation
- Celltex Therapeutics Corporation's estimated annual revenue is currently $6.4M per year.
- Celltex Therapeutics Corporation's estimated revenue per employee is $155,000
Employee Data
- Celltex Therapeutics Corporation has 41 Employees.
- Celltex Therapeutics Corporation grew their employee count by -5% last year.
Celltex Therapeutics Corporation's People
Name | Title | Email/Phone |
---|---|---|
1 | Chairman and CEO | Reveal Email/Phone |
2 | Co-Founder | Reveal Email/Phone |
3 | Chief Scientific Officer | Reveal Email/Phone |
4 | Human Resources Director | Reveal Email/Phone |
5 | Manufacturing Manager | Reveal Email/Phone |
6 | QC Manager | Reveal Email/Phone |
7 | Client Services Coordinator | Reveal Email/Phone |
8 | Research And Development Scientist | Reveal Email/Phone |
9 | Client Services Coordinator | Reveal Email/Phone |
10 | Quality Control Associate | Reveal Email/Phone |
Celltex Therapeutics Corporation Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $1.7M | 11 | -8% | N/A | N/A |
#2 | $14.9M | 96 | -6% | N/A | N/A |
#3 | $15.2M | 98 | 3% | $1.8M | N/A |
#4 | $1.6M | 10 | 0% | N/A | N/A |
#5 | $3.4M | 22 | 0% | N/A | N/A |
#6 | $2.8M | 18 | 50% | N/A | N/A |
#7 | $7.4M | 48 | -2% | N/A | N/A |
#8 | $0.8M | 5 | 0% | N/A | N/A |
#9 | $1.6M | 10 | 0% | N/A | N/A |
#10 | $16.3M | 105 | 62% | N/A | N/A |
What Is Celltex Therapeutics Corporation?
Celltex Therapeutics Corporation is a Houston, Texas-based biotechnology company focused on spearheading breakthroughs in regenerative medicine using adult, autologous Mesenchymal Stem Cells (MSCs).
keywords:N/AN/A
Total Funding
41
Number of Employees
$6.4M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8M | 41 | 5% | N/A |
#2 | $8M | 41 | N/A | N/A |
#3 | $4.8M | 41 | -9% | N/A |
#4 | $8.9M | 41 | -9% | N/A |
#5 | $8M | 41 | 8% | N/A |